Panacea Biotec Balance Sheet Health
Financial Health criteria checks 4/6
Panacea Biotec has a total shareholder equity of ₹8.4B and total debt of ₹206.8M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are ₹12.7B and ₹4.3B respectively.
Key information
2.5%
Debt to equity ratio
₹206.80m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹1.82b |
| Equity | ₹8.43b |
| Total liabilities | ₹4.29b |
| Total assets | ₹12.72b |
Recent financial health updates
Recent updates
Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S
Apr 04
Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All
Sep 23Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)
Jul 28How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?
Feb 14Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years
Jan 06Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?
Sep 17
If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today
Aug 03Financial Position Analysis
Short Term Liabilities: PANACEABIO's short term assets (₹5.4B) exceed its short term liabilities (₹3.3B).
Long Term Liabilities: PANACEABIO's short term assets (₹5.4B) exceed its long term liabilities (₹969.8M).
Debt to Equity History and Analysis
Debt Level: PANACEABIO has more cash than its total debt.
Reducing Debt: PANACEABIO's debt to equity ratio has reduced from 213.3% to 2.5% over the past 5 years.
Debt Coverage: PANACEABIO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if PANACEABIO's interest payments on its debt are well covered by EBIT.